New Logo.png
Provectus Biopharmaceuticals Announces Presentation of Full Study Data from Metastatic Neuroendocrine Cancer Phase 1 Trial of PV-10® at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
June 04, 2021 09:00 ET | Provectus Biopharmaceuticals Inc.
     — Systemic disease control achieved in heavily pre-treated liver cancer patients      — 83% DCR; median PFS of 9.2 months; median OS of 22.5 months; half of patients undergoing response...
22157.jpg
The Worldwide Interventional Oncology Industry is Projected to Reach $2.9 Billion by 2026 at a CAGR of 6.8% from 2020
June 01, 2021 07:43 ET | Research and Markets
Dublin, June 01, 2021 (GLOBE NEWSWIRE) -- The "Interventional Oncology Market by Product (Radiofrequency, microwave, embolization, guidewires), Procedure (Thermal, Non-Thermal Ablation, TACE, TARE,...
Logo (3).png
Electric Vehicle (EV) Market Worth $2,495.4 Billion by 2027, Growing at a CAGR of 33.6% From 2020- Exclusive Report by Meticulous Research®
May 11, 2021 07:10 ET | Meticulous Market Research Pvt. Ltd.
London, May 11, 2021 (GLOBE NEWSWIRE) -- According to a new market research report “Electric Vehicle (EV) Market by Vehicle Type (Passenger Vehicles, LCVs, HCVs, Two-wheelers, e-Scooters &...
Logo.png
Advanced Liver Cancer Drug Pipeline Prospers with an Inrush of Pharma Companies and Emerging Novel Therapies
April 29, 2021 20:30 ET | DelveInsight Business Research LLP
Los Angeles, USA, April 29, 2021 (GLOBE NEWSWIRE) -- Advanced Liver Cancer Drug Pipeline Prospers with an Inrush of Pharma Companies and Emerging Novel Therapies  A comprehensive analysis of...
Logo (3).png
Haematococcus Pluvialis Market Worth $148.1 million by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis by Meticulous Research® & EABA
November 10, 2020 08:00 ET | Meticulous Market Research Pvt. Ltd.
London, Nov. 10, 2020 (GLOBE NEWSWIRE) -- According to a new market research report titled “Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients (Oleoresin, Beadlets), Astaxanthin Bulk...
22157.jpg
Global $136.7 Billion Oncology Market to 2025
October 30, 2020 03:13 ET | Research and Markets
Dublin, Oct. 30, 2020 (GLOBE NEWSWIRE) -- The "Oncology Market - Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. Oncology Market size was valued at $136.7...
Adaptimmune logo Colour_white background_no strap.jpg
Promising Data from Phase 1 Trial with ADP-A2AFP in Liver Cancer at the International Liver Congress Confirm Safety Profile and Demonstrate Potential Benefit for Patients
August 28, 2020 10:30 ET | Adaptimmune Therapeutics plc
PHILADELPHIA and OXFORDSHIRE, United Kingdom, Aug. 28, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (“Adaptimmune”)(Nasdaq: ADAP), a leader in cell therapy to treat cancer, presented data...
Logo (3).png
Interventional Oncology Market Worth $1.5 Billion by 2025, Growing at a CAGR of 7.7% from 2019- Global Opportunity Analysis and Industry Forecasts by Meticulous Research®
June 18, 2020 15:33 ET | Meticulous Market Research Pvt. Ltd.
London, June 18, 2020 (GLOBE NEWSWIRE) -- Cancer is one of the leading causes of deaths worldwide. According to the Global Cancer Observatory (GLOBOCAN), in 2012, about 14.1 million new cancer cases...
Yiviva_Logo.jpg
Yiviva Announces Dosing of First Patient in Phase 2b Study of First-Line YIV-906 Plus Sorafenib Combination Therapy in the Treatment of Hepatocellular Carcinoma
April 06, 2020 07:00 ET | Yiviva
- First-in-class oncology therapeutic candidate YIV-906 applies an integrative systems biology approach -- Global study to evaluate efficacy, safety, and quality of life in patients with hepatitis...
首个抗肿瘤候选植物药“YIV-906”与索拉非尼联合治疗肝细胞癌的IIb期临床试验正式启动
April 06, 2020 07:00 ET | Yiviva
—— 利用整合系统生物学方法,由耶鲁大学郑永齐教授和医起共同开发的首个抗肿瘤候选植物药 中国上海,美国纽约, April 06, 2020 (GLOBE NEWSWIRE) -- 生物制药创新企业医起医药科技有限公司(Yiviva Inc.),在2020年初正式启动了YIV-906联合索拉非尼治疗乙型肝炎相关性肝细胞癌(HCC)的一线疗法IIb期研究,并于今年三月迎来了第一位受试者。 ...